Document is current

Any future updates will be listed below

798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update

Crossref DOI link: https://doi.org/10.1136/jitc-2020-SITC2020.0798

Published Online: 2020-12-10

Published Print: 2020-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark